Equities

Torrent Pharmaceuticals Ltd

TORNTPHARM:NSI

Torrent Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)3,167.10
  • Today's Change64.20 / 2.07%
  • Shares traded290.86k
  • 1 Year change+49.17%
  • Beta0.4938
Data delayed at least 15 minutes, as of Nov 22 2024 10:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments10,0407,2285,830
Total Receivables, Net21,94822,37119,216
Total Inventory23,24022,80925,189
Prepaid expenses590667515
Other current assets, total2982182,197
Total current assets56,11553,29252,947
Property, plant & equipment, net35,77834,59832,469
Goodwill, net3,3803,3752,595
Intangibles, net45,82850,89535,461
Long term investments333711679
Note receivable - long term3,3501,6081,666
Other long term assets270203246
Total assets150,606150,119130,998
LIABILITIES
Accounts payable20,89316,78816,744
Accrued expenses2,2432,6011,795
Notes payable/short-term debt16,37717,6519,230
Current portion long-term debt/capital leases7,16010,5439,866
Other current liabilities, total7,5796,8906,516
Total current liabilities54,25354,47344,151
Total long term debt16,68225,49221,600
Total debt40,21953,68640,697
Deferred income tax6,5614,0191,936
Minority interest------
Other liabilities, total4,5494,1543,782
Total liabilities82,04488,13871,469
SHAREHOLDERS EQUITY
Common stock1,6921,692846
Additional paid-in capital--043
Retained earnings (accumulated deficit)68,67862,28659,224
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1809)(1998)(584)
Total equity68,56261,98159,530
Total liabilities & shareholders' equity150,606150,119130,998
Total common shares outstanding338338338
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.